BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 30879122)

  • 1. Prospective comparison of whole-body MRI and
    Sawicki LM; Kirchner J; Buddensieck C; Antke C; Ullrich T; Schimmöller L; Boos J; Schleich C; Schaarschmidt BM; Buchbender C; Heusch P; Rabenalt R; Albers P; Antoch G; Müller HW; Hautzel H
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1542-1550. PubMed ID: 30879122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of
    Metser U; Chua S; Ho B; Punwani S; Johnston E; Pouliot F; Tau N; Hawsawy A; Anconina R; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Pond G; Scott AM; Tunariu N; Sidhu H; Emmett L
    J Nucl Med; 2019 Sep; 60(9):1253-1258. PubMed ID: 30902875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, Multisite, International Comparison of
    Emmett L; Metser U; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Punwani S; Pond G; Chua S; Ho B; Johnston E; Pouliot F; Scott AM
    J Nucl Med; 2019 Jun; 60(6):794-800. PubMed ID: 30442757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of
    Rajwa P; Heidenreich J; Drzezga A; Schmidt M; Shariat SF; Heidenreich A
    Prostate; 2024 Jan; 84(1):74-78. PubMed ID: 37750292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pictorial view on false positive findings of
    Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
    Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.
    Mazzone E; Gandaglia G; Robesti D; Rajwa P; Gomez Rivas J; Ibáñez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler WP; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Moreno Sierra J; Porpiglia F; Picchio M; Chiti A; van den Bergh R; Shariat SF; Montorsi F; Briganti A
    Eur Urol Oncol; 2024 Apr; 7(2):231-240. PubMed ID: 37689506
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sonni I; Dal Pra A; O'Connell DP; Ells Z; Benz M; Nguyen K; Yoon SM; Deng J; Smith C; Grogan T; Nickols NG; Cao M; Kishan AU; Calais J
    J Nucl Med; 2023 Jun; 64(6):902-909. PubMed ID: 36759200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presurgical
    Djaïleb L; Armstrong WR; Thompson D; Gafita A; Farolfi A; Rajagopal A; Grogan TR; Nguyen K; Benz MR; Hotta M; Barbato F; Ceci F; Schwarzenböck SM; Unterrainer M; Zacho HD; Juarez R; Cooperberg M; Carroll P; Washington S; Reiter RE; Eiber M; Herrmann K; Fendler WP; Czernin J; Hope TA; Calais J
    Eur Urol; 2023 Dec; 84(6):588-596. PubMed ID: 37482512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection efficacy of [
    Rosar F; Khreish F; Marlowe RJ; Schaefer-Schuler A; Burgard C; Maus S; Petto S; Bartholomä M; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2899-2909. PubMed ID: 37148297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of fully hybrid [
    Ghezzo S; Mapelli P; Samanes Gajate AM; Palmisano A; Cucchiara V; Brembilla G; Bezzi C; Suardi N; Scifo P; Briganti A; De Cobelli F; Chiti A; Esposito A; Picchio M
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):907-918. PubMed ID: 37897615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-Head Comparison of
    Exterkate L; Hermsen R; Küsters-Vandevelde HVN; Prette JF; Baas DJH; Somford DM; van Basten JA
    Eur Urol Oncol; 2023 Dec; 6(6):574-581. PubMed ID: 37230883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI,
    Akkaya H; Dilek O; Özdemir S; Taş ZA; Öztürk İS; Gülek B
    Diagn Interv Radiol; 2023 Sep; 29(5):647-655. PubMed ID: 37395389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of
    Esen B; Seymen H; Tarim K; Koseoglu E; Bolukbasi Y; Falay O; Selçukbiricik F; Molinas Mandel N; Kordan Y; Demirkol MO; Tilki D; Esen T
    Eur Urol Focus; 2023 Sep; 9(5):832-837. PubMed ID: 37032281
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Duan H; Moradi F; Davidzon GA; Liang T; Song H; Loening AM; Vasanawala S; Srinivas S; Brooks JD; Hancock S; Iagaru A
    Lancet Oncol; 2024 Apr; 25(4):501-508. PubMed ID: 38423030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Rosar F; Burgard C; Larsen E; Khreish F; Marlowe RJ; Schaefer-Schuler A; Maus S; Petto S; Bartholomä M; Ezziddin S
    Cancer Imaging; 2024 Feb; 24(1):27. PubMed ID: 38389092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent prostate cancer: combined role for MRI and PSMA-PET in
    Jannusch K; Bruckmann NM; Morawitz J; Boschheidgen M; Quick HH; Herrmann K; Fendler WP; Umutlu L; Stuschke M; Hadaschik B; Antoch G; Schimmöller L; Kirchner J
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38038758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study.
    Francolini G; Banini M; Di Cataldo V; Detti B; Caini S; Loi M; Simontacchi G; Desideri I; Greto D; Valzano M; Roghi M; Serni S; Vaggelli L; Salvestrini V; Visani L; Becherini C; Olmetto E; Franzese C; Baldaccini D; Scorsetti M; Sollini M; Chiti A; Meattini I; Valicenti RK; Livi L
    Prostate; 2023 Sep; 83(12):1201-1206. PubMed ID: 37290915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total-body PET/CT with half-dose [
    Liu Y; Li L; Qin Y; Chen Z; Zhao H; Wang X; Chen R
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):581-589. PubMed ID: 37819451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies.
    Wu Q; Bates A; Guntur P; Shamim SA; Nabi G
    Acad Radiol; 2024 Feb; 31(2):544-563. PubMed ID: 37770370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total-body [
    Wang Y; Chen Z; Zhu Y; Zhao H; Li L; Huang G; Xue W; Chen R; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4096-4106. PubMed ID: 37578502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.